Remifentanil hydrochloride is discontinued (DEA controlled substance). It is a mu opioid receptor agonist, anesthetic, and analgesic compound. Remifentanil was developed as an ultra-short-acting mu opioid receptor agonist with improved pharmacodynamic properties. References: Guo Z, Pang L, Jia X, Wang X, Su X, Li P, Mi W, Hao J. Intraoperative target-controlled infusion anesthesia application using remifentanil hydrochloride with etomidate in patients with severe burn as monitored using Narcotrend. Burns. 2015 Feb;41(1):100-5. doi: 10.1016/j.burns.2014.04.021. Epub 2014 Jun 13. PubMed PMID: 24931823.

纯度：≥98%

CAS：132539-07-2